and
viru
andv
associ
lethal
vascular
leak
syndrom
human
term
hantaviru
pulmonari
syndrom
hp
mechan
massiv
vascular
leakag
associ
hp
poorli
understood
howev
dysregul
compon
immun
respons
often
suggest
possibl
caus
alveolar
macrophag
found
alveoli
lung
repres
first
line
defens
mani
airborn
pathogen
determin
whether
alveolar
macrophag
play
role
hp
pathogenesi
alveolar
macrophag
deplet
adult
rodent
model
hp
close
resembl
human
hp
syrian
hamster
treat
intratrach
clodronateencapsul
liposom
control
liposom
challeng
andv
treatment
clodronateencapsul
liposom
result
signific
reduct
alveolar
macrophag
deplet
prevent
pathogenesi
prolong
diseas
deplet
also
significantli
reduc
amount
viru
lung
andvinfect
hamster
alter
neutrophil
recruit
chemokin
express
vascular
endotheli
growth
factor
vegf
level
hamster
bronchoalveolar
lavag
bal
fluid
earli
intranas
challeng
data
demonstr
alveolar
macrophag
may
play
limit
protect
role
earli
exposur
aerosol
andv
directli
contribut
hantaviru
diseas
pathogenesi
hamster
model
hp
hantavirus
continu
caus
diseas
worldwid
fdalicens
vaccin
effect
postexposur
prophylact
therapeut
much
attribut
poor
understand
mechan
hantaviru
diseas
pathogenesi
hantaviru
diseas
long
consid
immunemedi
diseas
howev
directli
manipul
syrian
hamster
model
continu
elimin
individu
immun
cell
type
numer
immun
cell
present
respiratori
tract
alveolar
macrophag
pois
defend
hantaviru
infect
antivir
respons
may
also
contribut
hantaviru
diseas
demonstr
like
prior
b
cell
studi
alveolar
macrophag
neither
prevent
hantaviru
infect
caus
hantaviru
diseas
studi
reflect
pathogenesi
hamster
model
help
us
rule
specif
cell
type
prompt
us
consid
potenti
mechan
diseas
effort
improv
outcom
human
hp
suggest
factor
possibl
host
deriv
render
endothelium
unabl
regul
barrier
integr
lead
pulmonari
edema
hantavirus
known
caus
diseas
multipl
rout
infect
predomin
rout
human
exposur
thought
inhal
excreta
infect
rodent
host
review
refer
suggest
cell
alveoli
may
play
import
role
clear
altern
contribut
diseas
caus
aerosol
hantavirus
alveolar
macrophag
found
alveoli
alveolar
duct
lung
repres
first
line
defens
mani
airborn
pathogen
crucial
regul
immun
system
activ
secret
either
proor
antiinflammatori
cytokin
also
vital
import
mainten
remodel
lung
tissu
via
product
growth
factor
cytokin
proteinas
play
key
role
gener
protect
cellular
immun
respons
follow
intranas
vaccin
activ
known
provid
critic
element
protect
pathogen
releas
chemokin
recruit
innat
immun
cell
type
area
infect
secret
antivir
cytokin
howev
activ
also
contribut
patholog
releas
cytokin
import
provid
protect
pathogen
alveolar
macrophag
secret
multipl
cytokin
activ
includ
transform
growth
factor
induc
nitric
oxid
synthas
ino
tumor
necrosi
factor
alpha
notabl
product
upregul
releas
proinflammatori
cytokin
contribut
initi
adapt
immun
respons
cytokin
chemokin
act
local
choreograph
immun
respons
import
protect
pulmonari
pathogen
number
cytokin
shown
promot
vascular
permeabl
pulmonari
edema
hallmark
pathogen
hantaviru
infect
correspondingli
studi
human
infect
hantaviru
detect
high
titer
proinflammatori
vasoact
cytokin
lung
tissu
hantaviru
pulmonari
syndrom
patient
high
number
cytokineproduc
cell
correl
sever
hp
patholog
moreov
system
level
inflammatori
cytokin
also
report
plasma
patient
hemorrhag
fever
renal
symptom
suggest
role
cytokin
diseas
pathogenesi
alveolar
macrophag
known
permiss
hantaviru
infect
appear
primari
target
infect
hantaviru
replic
alveolar
macrophag
less
effici
endotheli
cell
furthermor
found
associ
hantaviru
antigen
case
human
hp
caus
snv
case
european
hp
follow
puuv
infect
nt
clear
result
direct
infect
alveolar
macrophag
result
phagocytosi
despit
associ
hantaviru
infect
human
induc
modest
antivir
respons
cell
cultur
supernat
snvinfect
fail
caus
increas
permeabl
endotheli
cell
monolay
suggest
solubl
mediat
secret
infect
contribut
hantaviru
diseas
andv
caus
lethal
diseas
adult
syrian
hamster
resembl
hp
human
includ
clinic
sign
dyspnea
fluid
pleural
caviti
histopatholog
lung
spleen
diseas
incub
period
rapid
progress
first
sign
death
determin
contribut
hantaviru
diseas
hamster
deplet
use
clodronateencapsul
liposom
deliv
prior
andv
challeng
clodron
treatment
significantli
reduc
percentag
number
hamster
bronchial
alveolar
lavag
bal
fluid
intramuscular
im
intranas
andv
challeng
littl
effect
diseas
pathogenesi
deplet
result
slightli
rapid
uniform
diseas
cours
intranas
infect
suggest
may
provid
protect
exposur
airborn
andv
overal
data
suggest
directli
contribut
hantaviru
diseas
pathogenesi
syrian
hamster
model
human
hantaviru
pulmonari
syndrom
viru
cell
medium
andv
strain
propag
vero
cell
vero
atcc
crl
prepar
twiceplaquepurifi
andv
stock
describ
previous
cell
maintain
eagl
minimum
essenti
medium
earl
salt
contain
fetal
bovin
serum
fb
mm
hepe
ph
penicillinstreptomycin
invitrogen
gentamicin
sulfat
gml
co
incub
challeng
hantaviru
femal
syrian
hamster
week
age
harlan
indianapoli
anesthet
inhal
vapor
isofluran
use
impac
veterinari
anesthesia
machin
im
challeng
anesthet
hamster
inject
pfu
lethal
dose
ld
viru
dilut
phosphatebuff
salin
pb
ml
caudal
thigh
deliv
syring
fiveeighthsinch
needl
challeng
anesthet
hamster
administ
l
deliv
l
per
nari
plastic
pipett
tip
total
amount
andv
pfu
ld
group
hamster
typic
use
experiment
treatment
unless
otherwis
state
work
involv
hamster
perform
anim
biosafeti
level
laboratori
hamster
observ
two
three
time
daili
euthanasia
perform
anim
meet
earli
endpoint
criteria
macrophag
deplet
clodronateencapsul
liposom
mgml
clodron
clodrosom
refer
liposom
clodron
control
pbsencapsul
liposom
encapsom
refer
control
liposom
purchas
encapsula
nano
scienc
hamster
anesthet
use
g
bodi
weight
rat
kax
ketamineacepromazinxylazin
administ
im
inject
anim
place
dorsal
recumb
posit
otoscop
welch
allyn
use
visual
vocal
fold
vocal
fold
numb
topic
administ
lidocain
hcl
jelli
akorn
surflo
cathet
terumo
pass
vocal
fold
hamster
treat
either
ml
liposom
clodron
ml
control
liposom
attach
load
syring
cathet
aspir
content
lung
flow
cytometri
analysi
hamster
deepli
anesthet
ml
rat
g
extens
perfus
steril
salin
baxter
euthan
isol
alveolar
macrophag
anim
place
dorsal
recumb
posit
midlin
neck
incis
made
downward
dissect
perform
care
trachea
expos
second
incis
made
near
xyphoid
process
scissor
use
remov
rib
cage
expos
lung
care
taken
ensur
lung
damag
cathet
insert
trachea
lung
lavag
time
use
ml
edta
solut
bal
sampl
centrifug
g
min
cell
collect
wash
twice
pb
contain
fb
experi
cell
incub
min
block
buffer
consist
pb
contain
fb
normal
rat
serum
sigmaaldrich
prior
stain
antibodi
approxim
cell
stain
mouseantihamst
marco
clone
l
abd
serotec
follow
antimous
igm
clone
gml
biolegend
min
stain
cell
fix
cytofix
buffer
bd
bioscienc
min
analyz
facscalibur
flow
cytomet
bd
bioscienc
use
cellquest
softwar
bd
bioscienc
facscanto
ii
flow
cytomet
bd
bioscienc
use
facsdiva
softwar
bd
bioscienc
neutrophil
cell
number
bal
fluid
prepar
mathemat
determin
compar
cell
number
number
refer
microbead
sigma
use
follow
formula
n
cellsml
n
cell
event
dilut
factorn
bead
event
dilut
factor
n
beadsml
n
cellsml
number
cell
per
millilit
n
cell
event
number
cell
event
n
beadsml
number
bead
per
millilit
n
bead
event
number
bead
event
data
analyz
use
flowjo
softwar
treestar
plaqu
assay
hantaviru
plaqu
assay
perform
previous
describ
isol
rna
realtim
pcr
approxim
mg
lung
tissu
homogen
ml
trizol
reagent
use
gentlemac
tube
gentlemac
dissoci
rna
set
rna
extract
trizol
sampl
recommend
manufactur
concentr
extract
rna
determin
use
nanodrop
instrument
rais
final
concentr
ngl
realtim
pcr
conduct
biorad
cfx
thermal
cycler
use
invitrogen
power
sybr
green
rnatoc
onestep
kit
accord
manufactur
protocol
primer
sequenc
follow
andv
tga
gca
ccc
tcc
aag
aat
andv
gca
gtc
acg
agc
tgt
cycl
condit
min
min
cycl
min
data
acquisit
occur
follow
anneal
step
hamster
cytokin
elisa
antihamst
vascular
endotheli
growth
factor
vegfa
enzymelink
immunosorb
assay
elisa
kit
purchas
mybiosourc
use
accord
manufactur
recommend
prepar
tissu
histolog
tissu
fix
neutral
buffer
formalin
trim
process
embed
paraffin
cut
stain
hematoxylin
eosin
h
e
histopatholog
analysi
determin
presenc
andv
antigen
associ
alveolar
macrophag
coloc
endotheli
cell
serial
section
stain
follow
andv
immunohistochemistri
monoclon
antibodi
usamriid
number
and
viru
use
tissu
slide
normal
mous
igg
use
neg
serum
control
control
slide
briefli
unstain
section
deparaffin
rehydr
pretreat
trisedta
buffer
min
slide
rins
serumfre
protein
block
hors
serum
appli
min
monoclon
antibodi
appli
tissu
dilut
incub
h
room
temperatur
slide
treat
alkalin
phosphataselabel
secondari
mous
igg
antibodi
catalog
number
vector
laboratori
burlingam
ca
min
room
temperatur
slide
expos
immpact
vector
red
catalog
number
vector
laboratori
burlingam
ca
substratechromogen
min
rins
counterstain
hematoxylin
dehydr
coverslip
permount
catalog
number
fisher
immunohistochemistri
immunoperoxidas
assay
perform
use
rabbit
polyclon
antibodi
catalog
number
abcam
normal
rabbit
igg
use
neg
serum
control
control
slide
briefli
unstain
section
deparaffin
rehydr
subject
methanol
hydrogen
peroxid
block
rins
pretreat
trisedta
buffer
min
slide
rins
serumfre
protein
block
goat
serum
appli
min
polyclon
antibodi
appli
tissu
dilut
incub
overnight
room
temperatur
slide
treat
envis
horseradish
peroxidaselabel
secondari
antibodi
catalog
number
dako
carpinteria
ca
min
room
temperatur
section
expos
dab
substratechromogen
min
rins
counterstain
hematoxylin
dehydr
coverslip
permount
statist
analysi
surviv
curv
compar
kaplanmei
surviv
analysi
log
rank
comparison
dunnett
correct
comparison
viral
genom
infecti
viru
alveolar
macrophag
neutrophil
percentag
number
elisa
cytokin
titer
done
use
oneway
analysi
varianc
anova
tukey
multiplecomparison
test
p
valu
less
consid
signific
analys
conduct
use
graphpad
prism
version
liposom
clodron
use
extens
deplet
mani
anim
model
includ
syrian
hamster
syrian
hamster
identifi
high
forward
light
scatter
high
side
light
scatter
fsc
hi
ssc
hi
marcoexpress
cell
hamster
bal
fluid
fig
intratrach
administr
clodronateencapsul
liposom
found
effect
reduc
number
hamster
andv
infect
determin
reduct
either
marco
cell
fig
fsc
hi
ssc
hi
cell
fig
histolopatholog
analysi
hamster
lung
tissu
fig
andv
infect
hamster
begin
understand
role
play
andv
diseas
pathogenesi
hamster
treat
intratrach
clodronateencapsul
liposom
clodrosom
control
pbsencapsul
liposom
encapsom
day
one
group
hamster
left
untreat
hamster
challeng
pfu
ld
andv
im
ten
day
later
number
percentag
hamster
bal
fluid
determin
control
liposom
treatment
induc
increas
number
alveolar
macrophag
fig
comparison
clodron
treatment
result
signific
reduct
total
number
alveolar
macrophag
fig
macrophag
deplet
prevent
diseas
hamster
fig
significantli
alter
mean
time
death
liposom
clodron
day
control
liposom
day
untreat
day
mean
time
death
follow
control
liposom
treatment
significantli
longer
untreat
anim
day
versu
day
p
longer
clodronatetr
anim
deplet
also
result
increas
andv
titer
lung
measur
pcr
fig
data
suggest
despit
becom
activ
import
protect
intramuscular
andv
challeng
contribut
diseas
pathogenesi
follow
intramuscular
challeng
serial
section
lung
tissu
group
reveal
presenc
andv
antigen
coloc
endotheli
cell
capillari
larger
vessel
fig
regardless
treatment
differ
observ
pathogenesi
hpslike
diseas
andvinfect
hamster
hamster
group
exhibit
sign
mild
moder
inflam
mation
interstiti
pneumonia
alveolar
fibrin
deposit
edema
characterist
andv
infect
also
notic
multifoc
foci
neutrophil
inflamm
along
mesotheli
hypertrophi
atelectasi
presenc
necroticapoptot
debri
rare
consist
detect
viral
genom
pcr
immunohistochemistri
analysi
reveal
littl
differ
overal
viral
load
within
endotheli
cell
follow
clodron
treatment
interestingli
identifi
alveolar
macrophag
found
andvinfect
hamster
neg
and
viru
although
posit
cytoplasm
stain
fig
deplet
prevent
diseas
follow
intranas
andv
challeng
alveolar
macrophag
like
involv
defens
airborn
pathogen
understand
protect
pathogen
respons
elicit
inhal
hantavirus
deplet
prior
intranas
andv
challeng
group
hamster
treat
intratrach
liposom
clodron
control
liposom
day
one
group
hamster
left
untreat
hamster
challeng
pfu
ld
andv
ten
day
later
number
percentag
hamster
bal
fluid
determin
similar
seen
intramu
untreat
andvinfect
hamster
c
normal
uninfect
hamster
stain
antibodi
specif
dab
brown
andv
np
alkalin
phosphatas
red
andv
np
stain
coloc
cell
adjac
serial
section
normal
hamster
tissu
remain
neg
andv
np
differ
seen
pattern
andor
andv
np
stain
across
treatment
group
e
alveolar
macrophag
untreat
andvinfect
hamster
evalu
presenc
andv
np
found
posit
evid
posit
stain
andv
np
detect
cular
challeng
day
intranas
challeng
percentag
total
number
untreat
control
liposometr
anim
compar
fig
control
liposom
treatment
result
trend
toward
increas
number
compar
untreat
anim
differ
signific
comparison
liposom
clodron
treatment
result
signific
reduct
percentag
total
number
percentag
remain
significantli
reduc
fol
b
ten
day
day
b
postandv
challeng
number
determin
flow
cytometri
gate
fsc
hi
ssc
hi
cell
describ
fig
hamster
bal
sampl
p
p
ns
signific
c
number
day
untreat
andvchalleng
hamster
directli
compar
p
deplet
prevent
diseas
hamster
surviv
anim
seroconvert
indic
expos
viru
data
shown
e
lung
tissu
isol
hamster
day
postchalleng
evalu
viral
genom
rtpcr
low
liposom
clodron
treatment
day
intranas
challeng
fig
surpris
though
observ
number
day
untreat
group
significantli
lower
number
untreat
group
day
fig
phenomenon
seen
untreat
group
number
control
liposometr
anim
remain
similar
day
although
total
number
liposom
clodronatetr
anim
lower
day
day
differ
number
liposom
clodronatetr
anim
untreat
anim
day
signific
howev
differ
number
control
liposometr
anim
untreat
anim
day
signific
reduct
prevent
diseas
hamster
fig
deplet
result
uniform
slightli
rapid
diseas
cours
mean
time
death
liposom
clodron
day
control
liposom
day
treatment
day
andv
titer
lung
significantli
differ
liposom
clodronatetr
hamster
either
day
day
determin
presenc
viral
genom
measur
pcr
fig
howev
trend
toward
increas
andv
copi
number
lung
liposom
clodronatetr
anim
day
postchalleng
level
hamster
bal
sampl
significantli
higher
peak
diseas
earlier
time
point
fig
day
versu
day
deplet
affect
express
earli
infect
interestingli
treatment
either
liposom
clodron
control
liposom
result
increas
detect
compar
untreat
hamster
could
reflect
higher
number
neutrophil
present
bal
sampl
group
respect
fig
reduct
reduc
amount
detect
bal
sampl
day
intramuscular
challeng
fig
similar
amount
detect
bal
sampl
day
intranas
challeng
remark
level
peak
diseas
follow
intranas
challeng
day
nearli
twice
detect
peak
diseas
follow
intramuscular
challeng
possibl
reflect
differ
activ
viru
administ
directli
lung
data
suggest
contribut
diseas
pathogenesi
may
contribut
degre
protect
intranas
andv
challeng
deplet
alter
neutrophil
recruit
earli
late
intranas
andv
challeng
alveolar
macrophag
coordin
mani
aspect
immun
respons
airborn
pathogen
includ
recruit
immun
cell
type
neutrophil
peak
hantaviru
diseas
follow
intramuscular
infect
andv
day
observ
decreas
neutrophil
chemoattract
bal
sampl
amdeplet
hamster
compar
untreat
andvinfect
hamster
suggest
may
import
sourc
hantaviru
infect
lung
fig
howev
express
neutrophil
chemoattract
bal
sampl
hamster
remain
unchang
fig
correspondingli
also
littl
signific
chang
number
neutrophil
found
hamster
bal
sampl
day
intramuscular
challeng
fig
comparison
investig
role
recruit
neutrophil
follow
intranas
challeng
found
earli
diseas
pathogenesi
day
express
reduc
liposom
clodronateand
control
liposometr
hamster
compar
untreat
andvinfect
hamster
fig
e
also
found
control
liposom
treatment
result
increas
number
recruit
fig
liposom
clodron
treatment
result
increas
number
neutrophil
fig
peak
diseas
follow
intranas
andv
challeng
day
express
reduc
approxim
compar
express
seen
day
moreov
express
depend
treatment
equival
amount
detect
bal
sampl
hamster
fig
e
neutrophil
number
reduc
liposom
clodronatetr
anim
day
compar
number
observ
day
neutrophil
number
control
liposometr
untreat
hamster
remain
virtual
unchang
day
fig
contrast
number
control
liposometr
hamster
remain
elev
day
despit
overal
drop
number
untreat
hamster
fig
b
data
suggest
may
regul
neutrophil
recruit
lung
earli
hantaviru
infect
contribut
significantli
neutrophil
recruit
toward
peak
diseas
pathogenesi
recent
vascular
endotheli
growth
factor
vegf
hypothes
play
role
hantaviru
diseas
pathogenesi
moreov
known
sourc
vegf
therefor
ask
whether
vegf
express
lung
hamster
infect
andv
depend
presenc
compar
normal
uninfect
hamster
vegfa
express
bal
hamster
day
intranas
andv
challeng
slightli
significantli
elev
fig
interestingli
time
peak
diseas
day
almost
increas
vegfa
protein
macrophag
deplet
enhanc
vegfa
bal
sampl
late
infect
observ
differ
vegf
titer
andvinfect
hamster
bal
sampl
presenc
absenc
howev
deplet
vegfa
express
bal
fluid
day
equival
amount
vegfa
detect
hamster
bal
sampl
day
similar
increas
vegf
observ
control
liposometr
hamster
data
demonstr
vegf
express
enhanc
hamster
infect
andv
suggest
may
regul
express
vegf
cell
type
lung
major
sourc
vegf
hantaviru
diseas
pathogenesi
human
lung
surfac
area
approxim
contain
averag
million
alveoli
constant
contact
outsid
world
environ
homeostasi
along
endothelialepitheli
border
must
maintain
allow
oxygen
carbon
dioxid
freeli
exchang
howev
homeostat
mechan
must
remain
pliabl
enough
allow
immun
respons
clear
invad
pathogen
often
consid
first
line
defens
respiratori
pathogen
estim
billion
resid
alveoli
human
lung
uniqu
juxtapos
maintain
lung
homeostasi
well
orchestr
protect
airborn
virus
bacteria
case
hantavirus
predomin
rout
human
exposur
thought
inhal
excreta
infect
rodent
host
review
refer
suggest
alveolar
macrophag
may
play
import
role
clear
altern
contribut
diseas
caus
aerosol
hantavirus
albeit
rare
sever
case
hantaviru
diseas
report
human
follow
parenter
exposur
result
bite
infect
rodent
case
diseas
result
parenter
infect
virtual
ident
diseas
follow
aerosol
infect
differ
slight
differ
diseas
kinet
similarli
syrian
hamster
experiment
infect
andv
intramuscular
challeng
develop
diseas
indistinguish
diseas
exhibit
follow
intranas
exposur
differ
slight
differ
diseas
kinet
number
pfu
need
develop
uniformli
lethal
diseas
given
extens
similar
diseas
like
mechan
diseas
cell
type
respons
diseas
ident
regardless
rout
exposur
consist
hypothesi
demonstr
alveolar
macrophag
play
margin
role
protect
hamster
lethal
hantaviru
infect
contribut
diseas
caus
either
intranas
intramuscular
hantaviru
infect
alveolar
macrophag
contribut
defens
mani
aerosol
pathogen
mani
case
respons
critic
host
protect
model
vaccinia
viru
respiratori
syncyti
viru
rsv
influenza
viru
infect
deplet
alveolar
macrophag
result
greater
viral
replic
dissemin
overal
increas
sever
infect
case
reduc
level
protect
absenc
alveolar
macrophag
like
due
impair
initi
antivir
respons
result
abolish
earli
cytokin
chemokin
releas
inhibit
immun
cell
activ
recruit
addit
schneider
et
al
demonstr
alveolar
macrophag
deplet
mice
prior
infect
influenza
viru
mice
exhibit
lower
percent
oxygen
satur
oxygen
partial
pressur
po
argu
import
maintain
lung
function
infect
howev
mechan
alveolar
macrophag
use
protect
pathogen
also
implic
caus
diseas
increas
vascular
permeabl
model
acut
lung
injuri
caus
infecti
diseas
agent
human
metapneumoviru
hmpv
pseudomona
aeruginosa
well
chronic
obstruct
pulmonari
diseas
copd
nonischem
inflammatori
lung
injuri
alveolar
macrophag
may
also
serv
reservoir
pathogen
hmpv
measl
viru
legionella
pneumophila
may
indirectli
contribut
pathogenesi
differ
diseas
caus
pathogen
allow
replic
dissemin
still
enhanc
diseas
presenc
alveolar
macrophag
may
alway
reflect
direct
contribut
way
proinflammatori
cytokin
angiogen
factor
may
indirectli
result
increas
immun
cell
recruit
seen
mous
model
mous
hepat
viru
type
infect
role
play
diseas
caus
classic
hemorrhag
fever
virus
less
well
understood
alveolar
macrophag
express
primari
secondari
receptor
hantavirus
integrin
complement
receptor
ebola
viru
dcsign
dcsignr
correspondingli
known
permiss
hantaviru
ebola
viru
infect
howev
case
infect
less
effici
fail
induc
sustain
inflammatori
respons
compar
primari
target
infect
virus
evid
hantaviru
infect
induc
apoptosi
antigen
yellow
fever
viru
transmit
bite
aed
aegypti
mosquito
found
insid
rough
endoplasm
reticulum
golgi
complex
suggest
viral
replic
occur
cell
unknown
whether
play
role
diseas
pathogenesi
act
viru
reservoir
also
unknown
whether
hemorrhag
fever
virus
commonli
target
monocyt
lineag
cell
dengu
viru
crimean
congo
hemorrhag
fever
viru
target
way
contribut
human
diseas
alveolar
macrophag
known
permiss
hantaviru
infect
less
clear
extent
act
reservoir
hantavirus
earliest
character
hp
mori
colleagu
describ
find
viral
antigen
low
number
larg
cell
identifi
macrophag
lung
similarli
li
klein
demonstr
norway
rat
alveolar
macrophag
could
infect
seoul
viru
abil
support
effici
replic
viru
significantli
reduc
compar
endotheli
cell
analysi
andv
nucleoprotein
np
associ
limit
intramuscular
challeng
similar
trend
report
safronetz
colleagu
note
even
end
stage
hantaviru
diseas
hamster
infect
intranas
andv
occasion
alveolar
lumin
cell
like
alveolar
macrophag
found
stain
posit
hantaviru
antigen
coupl
see
differ
hp
patholog
hamster
follow
either
im
challeng
analysi
done
peak
diseas
pathogenesi
follow
im
challeng
day
andv
np
stain
lung
endothelium
nearli
continu
suggest
likelihood
andvam
interact
would
high
follow
intranas
challeng
taken
togeth
observ
deplet
result
signific
chang
lung
andv
titer
fig
inabl
detect
presenc
andv
np
associ
hamster
fig
suggest
serv
primari
reservoir
hantaviru
replic
dysfunct
due
direct
hantaviru
infect
unlik
hamster
respond
andv
infect
entir
clear
alveolar
macrophag
gener
need
walk
fine
line
homeostasi
host
defens
protect
host
prevent
catastroph
inflamm
one
way
contribut
lung
protect
phagocyt
particul
matter
enter
lung
suggest
may
also
contribut
clearanc
andv
lung
hamster
earli
intranas
andv
challeng
saw
trend
toward
increas
detect
viral
genom
hamster
deplet
although
deplet
significantli
alter
amount
live
viru
viral
genom
detect
lung
tissu
late
time
point
infect
fig
f
hamster
devoid
also
develop
diseas
faster
untreat
controltr
andvinfect
hamster
interestingli
highest
number
surviv
anim
found
control
liposometr
anim
fig
correspondingli
group
also
greater
number
liposom
clodronatetr
untreat
anim
fig
c
like
model
could
suggest
earli
infect
help
prevent
spread
infect
reduc
infecti
viru
lung
may
help
control
rate
diseas
pathogenesi
progress
later
time
infect
similar
level
viral
genom
andor
infecti
viru
found
lung
hamster
support
argument
contribut
substanti
immun
respons
andv
earli
infect
less
later
time
andv
primarili
replic
endotheli
cell
also
consist
reduc
number
detect
day
compar
day
second
way
contribut
lung
protect
modul
immun
respons
lung
presenc
harmless
particul
dust
may
go
far
suppress
antigenspecif
adapt
immun
respons
either
directli
suppress
tissueresid
cell
suppress
lungresid
dendrit
cell
thu
prevent
migrat
drain
lymph
node
initi
immun
respons
howev
case
aerosol
pathogen
activ
sult
chang
phenotyp
regul
lung
homeostasi
cell
capabl
coordin
particip
inflammatori
immun
respons
human
make
littl
expos
snv
compar
lipopolysaccharid
lp
suggest
hantaviru
may
ineffect
activ
correspondingli
notic
littl
differ
amount
bal
fluid
hamster
presenc
absenc
follow
infect
andv
intramuscularli
fig
late
time
intranas
infect
fig
case
intramuscular
inject
viru
clear
whether
would
effect
stimul
sinc
assum
infect
endothelium
would
occur
directli
via
blood
inhal
observ
increas
amount
bal
sampl
day
day
postintranas
challeng
indic
inflammatori
respons
occur
howev
late
time
deplet
macrophag
reduc
amount
detect
suggest
major
sourc
late
infect
somewhat
surprisingli
earli
time
day
intranas
challeng
deplet
result
increas
bal
sampl
one
explan
hamster
prone
immunosuppress
phenotyp
deplet
cell
type
includ
neutrophil
endotheli
cell
cell
epitheli
cell
longer
prevent
produc
fact
control
liposometr
anim
also
increas
level
may
reflect
increas
number
induc
control
liposom
treatment
resid
time
control
liposom
treatment
may
retain
immunosuppress
phenotyp
newli
recruit
could
expect
markedli
differ
phenotyp
prior
adopt
suppress
function
immun
sentinel
one
primari
role
orchestr
immun
respons
recruit
immun
cell
type
lung
model
acut
lung
injuri
includ
pneumonia
induc
lp
p
aeruginosa
pneumonia
infect
deplet
attenu
recruit
neutrophil
lung
indic
key
sourc
neutrophil
chemoattract
convers
model
appear
play
greater
role
neg
regul
neutrophil
migrat
deplet
amplifi
neutrophil
recruit
neutrophil
migrat
respons
number
chemoattract
includ
mous
human
major
sourc
liposom
clodron
treatment
result
decreas
detect
bal
sampl
day
follow
intramuscular
andv
challeng
fig
also
result
decreas
day
follow
intranas
challeng
fig
surprisingli
decreas
liposom
clodronatetr
anim
follow
intranas
challeng
accompani
increas
bal
neutrophil
fig
moreov
control
liposom
treatment
also
result
decreas
recruit
new
rather
neutrophil
one
possibl
explan
appar
paradox
import
sourc
hamster
hamster
neutrophil
preferenti
respond
chemokin
monocyt
chemoattract
kc
may
abund
absenc
altern
preferenti
secret
cell
type
neutrophil
hamster
presenc
suppress
neutrophil
migrat
alveolar
macrophag
deplet
neutrophil
freeli
migrat
lung
act
spong
soak
free
chemokin
reduc
overal
level
bioavail
similar
explan
could
hold
true
decreas
abund
follow
control
liposom
treatment
newli
arriv
act
chemokin
spong
closer
analysi
kinet
express
follow
alveolar
macrophag
deplet
would
necessari
elucid
possibl
express
day
follow
intranas
andv
challeng
similar
across
treatment
group
substanti
lower
detect
andvalon
hamster
day
whether
reflect
decreas
number
day
versu
day
whether
natur
attempt
hamster
downregul
lung
inflamm
yet
determin
anoth
potent
neutrophil
chemoattract
produc
number
cell
type
respiratori
tract
includ
activ
alveolar
macrophag
airway
epitheli
airway
smooth
muscl
airway
endotheli
cell
respond
inflammatori
stimuli
like
limit
data
chemokin
regul
human
hantaviru
infect
neither
sin
nombr
viru
hantaan
viru
induc
within
h
vitro
infect
human
lung
microvascular
endotheli
cell
htnv
induc
time
later
h
suggest
may
relev
hfr
hp
analysi
sera
human
hp
case
fail
detect
chang
although
signific
increas
granulocytemacrophag
colonystimul
factor
gmcsf
mcsf
detect
myeloid
cell
differenti
growth
activ
factor
gmcsf
mcsf
could
implic
macrophag
dendrit
cell
diseas
although
result
suggest
necessarili
due
recruit
cell
type
macrophag
intriguingli
higher
concentr
gmcsf
serum
found
femal
hfr
patient
infect
puuv
male
counterpart
potenti
link
express
hfr
sever
howev
male
femal
like
develop
clinic
hfr
follow
puuv
infect
differ
hfr
diseas
sever
human
infect
puuv
render
link
hfr
diseas
suspect
whether
chemokin
follow
similar
pattern
express
human
hfr
yet
determin
believ
first
report
hamsterspecif
elisa
kit
commerci
vendor
use
syrian
hamster
anim
model
given
rel
short
time
interv
publish
syrian
hamster
genom
commerci
avail
elisa
kit
discount
possibl
cytokin
express
pattern
see
follow
liposom
clodronatecontrol
liposom
treatment
andvinfect
hamster
relat
specif
kit
measur
reproduc
interpret
within
context
paramet
measur
experi
eg
surviv
number
verifi
independ
report
potenti
role
vegf
hantaviru
diseas
pathogenesi
recent
receiv
great
deal
attent
vitro
hantaviru
infect
sensit
endotheli
cell
vegf
render
hyperperm
process
involv
vecadherin
potenti
integrin
similarli
increas
level
vegf
detect
pleural
effluent
patient
acut
hp
serum
sampl
acutephas
hfr
patient
alveolar
macrophag
known
express
vegf
pulmonari
infect
form
acut
lung
injuri
suggest
may
respond
similarli
hantaviru
infect
still
fact
hamster
infect
andv
develop
diseas
fig
suggest
significantli
influenc
express
vegf
hamster
signific
increas
vegf
express
bal
fluid
andvinfect
hamster
late
infect
day
observ
compar
seen
normal
hamster
expect
level
vegf
detect
bal
fluid
andvinfect
anim
nearli
ident
later
time
infect
day
regardless
presenc
absenc
fig
howev
contrari
expect
deplet
result
signific
increas
level
vegf
bal
fluid
andvinfect
hamster
earli
time
intranas
challeng
interestingli
macrophag
deplet
anim
prior
intranas
challeng
anim
develop
diseas
faster
either
untreat
andvinfect
anim
anim
receiv
control
liposom
treatment
would
seem
support
suggest
vegf
contribut
hantaviru
diseas
would
argu
sole
sourc
vegf
pulmonari
epitheli
cell
neutrophil
known
sourc
vegf
lung
could
contribut
increas
level
vegf
seen
andvinfect
hamster
epitheli
cell
primari
target
hantavirus
thu
unlik
express
vegf
result
direct
infect
express
could
induc
inflammatori
cytokin
produc
cell
infect
hypoxia
caus
hp
recent
role
neutrophil
vascular
leakag
caus
htnv
infect
scid
mice
suggest
correspondingli
liposom
clodron
treatment
result
signific
increas
bal
fluid
vegf
neutrophil
number
earli
infect
day
whether
deplet
neutrophil
hamster
alter
hantaviru
diseas
pathogenesi
express
vegf
hamster
remain
determin
role
immun
cell
type
may
play
diseas
pathogenesi
may
limit
direct
antivir
respons
cytokin
cell
neutrophil
monocyt
lymphocyt
recruit
site
infect
undergo
process
transendotheli
cell
migrat
highli
regul
integrin
cadherin
junction
adhes
molecul
prevent
vascular
leakag
process
hantavirus
inactiv
dysregul
beta
integrin
vecadherin
make
possibl
infect
endotheli
cell
may
abl
reform
junction
complex
follow
paracellular
diapedesi
lead
vascular
leakag
presum
would
lead
visibl
gap
endotheli
cell
born
electron
microscopi
em
analysi
hantavirusinfect
endothelium
human
hamster
altern
neutrophil
also
possess
abil
migrat
directli
endotheli
cell
via
transcellular
migrat
process
endotheli
cell
form
dome
control
rhoa
factin
neutrophil
prevent
vascular
leakag
endotheli
cell
polymorphonuclear
leukocyt
pmn
adher
often
display
mani
vesicl
extend
continu
cell
membran
endotheli
cell
similar
seen
endotheli
cell
hantavirusinfect
hamster
dysregul
dome
format
could
potenti
allow
direct
flow
serum
protein
infect
endotheli
cell
manner
irrespect
notic
gap
format
endothelium
smallanim
model
invalu
tool
studi
pathogenesi
diseas
caus
neglect
infecti
diseas
agent
and
viru
howev
util
hamster
model
well
role
immun
respons
hantaviru
diseas
pathogenesi
contenti
previous
other
demonstr
ablat
adapt
b
cell
respons
andv
infect
hamster
alter
cours
diseas
use
syrian
hamsterand
viru
lethal
diseas
model
demonstr
anoth
compon
immun
system
directli
respons
hpslike
diseas
caus
andv
hamster
mechan
hantavirus
caus
diseas
human
hamster
alik
clear
mani
mechan
diseas
immun
relat
viru
intrins
propos
make
difficult
aspect
immun
respons
hantaviru
infect
like
import
protect
viral
clearanc
even
view
contribut
diseas
still
necessari
continu
evalu
immun
cell
type
seek
understand
role
contribut
diseas
protect
follow
hantaviru
infect
